Categoría

ACE/ACU

Home > Tipos de Proyecto > ACE/ACU (Page 20)

Montalar J, Cajaraville G, Carreras MJ, Rubio MJ, García-San Andrés B, Oyagüez I, Casado MA

 

 

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD monotherapy in relapsed platinum-sensitive ovarian cancer patients: a cost-effectiveness analyses in Spain
Eur J Hosp Pharmacy. 2012;19:364-69

Roman A, Barberà JA, Escribano P, Sala ML, Febrer L, Oyagüez I, Sabater E, Casado MA

 

 

Cost effectiveness of prostacyclins in pulmonary arterial hypertension
Appl Health Econ Health Policy. 2012;10(3):175-88

García-Ruiz A, Perez-Costillas L, Montesinos AC, Alcalde J, Oyagüez I, Casado MA

 

 

Efficiency of antipsychotics in reducing schizophrenia relapses
Health Econ Rev. 2012;2:8

Grau S, de la Camara R, Sabater FJ, Jarque I, Carreras E, Casado MA, Sanz MA

 

 

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
BMC Infect Dis. 2012;12:83 doi:10.1186/1471-2334-12-83

García-Jurado L, Oyagüez I, Casado MA, Tural C, González García J, Ortega E, Pineda JA

 

 

Evaluación Económica de la Elastografía de Transición (FibroScan®) en el diagnóstico de fibrosis hepática en pacientes con hepatitis C coinfectados con VIH
Enferm Infecc Microbiol Clin. 2012;30(6):294-9

Sánchez-de la Rosa R, Sabater E, Casado MA, Arroyo R

 

 

Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients
J Med Econ. 2012;15(3):1–10

González-Juanatey JR, Álvarez-Sabin J, Lobos JM, Martínez-Rubio A, Reverter JC, Oyagüez I, González-Rojas N, Becerra V

 

 

Economic evaluation of dabigatran etexilate in stroke prevention in patients with non valvular atrial fibrillation
21st European Stroke Conference (ESC). Lisbon, Portugal. 22-25 may 2012

POSTER

González-Juanatey JR, Álvarez-Sabin J, Lobos JM, Martínez-Rubio A, Reverter JC, Oyagüez I, González-Rojas N, Becerra V

 

 

Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España
32 jornadas de Economía de la Salud (AES). Bilbao, España. 15-18 may 2012

POSTER 

Domínguez-Gil A, Alegre A, López A, Oyagüez I, Gutierrez L, Restovic G, Casado MA

 

 

Cost-effectiveness analysis of febrile neutropenia (FN) prophylaxis with pegfilgrastim in non-Hodgkin Lymphoma (NHL) patients treated with chemotherapy in Spain
17th Congress of European Association of Hospital Pharmacist (EAHP). Milan, Italy. 21-23 mar 2012